Asset
PEGAPAMODUTIDE
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02188303 | phase1 | terminated | 2014-07-01 | 2014-12-01 | OPKO Health, Inc. | A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants |
| NCT02119819 | phase2 | completed | 2014-04-01 | 2015-08-01 | OPKO Health, Inc. | A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes |
FDA applications (0)
This company has no applications containing this asset.